TOKYO, Japan (AFP) — Japan has agreed to buy 150 million doses of Novavax’s coronavirus vaccine, with Japanese firm Takeda expecting to manufacture the formula for distribution early next year, the drugmaker said Tuesday. The cost of the deal was not announced, and it is contingent on the vaccine being approved in Japan. Takeda will be in charge of carrying out local clinical trials. So far, Japan has approved the Pfizer/BioNTech, Moderna and AstraZeneca jabs, […]